Meet The Expert: Steve Gray and Kiran Musunuru

In the second video of the Meet the Expert Webinar Series, Drs. Steve Gray and Kiran Musunuru share their experience and tips for preparing an IND application for gene therapy.

Meet the Expert is a webinar series presented by the Somatic Cell Genome Editing (SCGE) Consortium. This series aims to connect researchers within the consortium and the greater scientific community with experts in the gene therapy space.

SCGE Releases Gene Therapy Trial Browser

The SCGE has created a Gene Therapy Clinical Trial Browser. This publicly accessible, free database was created for the benefit of users seeking information on gene therapy development. The information within integrates various sources to give a comprehensive overview of the gene therapy clinical trial landscape.

SCGE Meet the Researcher Video Series

The TCDC is creating a video series where we interview different members that are part of Phase 2 of the SCGE Consortium. You can find these videos on our website or on the SCGE YouTube channel.

Meet the Expert: Peter Marks and P.J. Brooks

In the first video of the Meet the Expert Webinar Series, Drs. Peter Marks and P.J. Brooks discuss the current landscape of the gene therapy regulatory and approval process, and the vision for where this can go in the future.

Bespoke Gene Therapy Consortium (BGTC) Regulatory Playbook

The Bespoke Gene Therapy Consortium (BGTC) drew upon their consortium subject matter experts and the collective experience of the scientific community to create a playbook that aims to bring safe, effective, and transformative gene therapies to patients in need.

Program Snapshot

The goal of the SCGE program is to accelerate the development of genome editing therapies into the clinic. For Phase 2, there are four program initiatives:

1. Developing technologies and assays for safety and efficacy studies
2. Optimizing genome editing-based therapeutic leads to support advancement towards clinical trials
3. Supporting novel genome editing clinical trials for more than one disease
4. Fostering collaboration and sharing new technologies and protocols with the public and research community

For ethical, legal, and safety reasons, the SCGE program does NOT support any research activities on genome editing in reproductive (germ) cells.

Learn more about individual and collaborative research projects, as well as the SCGE program and deliverables, below: